1. 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS): Developed by the task force on cardio-oncology of the European Society of Cardiology (ESC). (26th August 2022) Authors: Lyon, Alexander R; López-Fernández, Teresa; Couch, Liam S; Asteggiano, Riccardo; Aznar, Marianne C; Bergler-Klein, Jutta; Boriani, Giuseppe; Cardinale, Daniela; Cordoba, Raul; Cosyns, Bernard; Cutter, David J; de Azambuja, Evandro; de Boer, Rudolf A; Dent, Susan F; Farmakis, Dimitrios; Gevaert, S... Journal: European heart journal Issue: Volume 43:Number 41(2022) Page Start: 4229 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Amino-terminal Pro-B-Type Natriuretic Peptide Among Patients Living With Both Human Immunodeficiency Virus and Heart Failure. (28th September 2019) Authors: Alvi, Raza M; Zanni, Markella V; Neilan, Anne M; Hassan, Malek Z O; Tariq, Noor; Zhang, Lili; Afshar, Maryam; Banerji, Dahlia; Mulligan, Connor P; Rokicki, Adam; Awadalla, Magid; Januzzi, James L; Neilan, Tomas G Journal: Clinical infectious diseases Issue: Volume 71:Number 5(2020) Page Start: 1306 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Are we underestimating the potential for cardiotoxicity related to immune checkpoint inhibitors?. (8th December 2020) Authors: Totzeck, Matthias; Lutgens, Esther; Neilan, Tomas G Journal: European heart journal Issue: Volume 42:Number 16(2021) Page Start: 1632 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Association Between Immune Checkpoint Inhibitors With Cardiovascular Events and Atherosclerotic Plaque. Issue 24 (15th December 2020) Authors: Drobni, Zsofia D.; Alvi, Raza M.; Taron, Jana; Zafar, Amna; Murphy, Sean P.; Rambarat, Paula K.; Mosarla, Rayma C.; Lee, Charlotte; Zlotoff, Daniel A.; Raghu, Vineet K.; Hartmann, Sarah E.; Gilman, Hannah K.; Gong, Jingyi; Zubiri, Leyre; Sullivan, Ryan J.; Reynolds, Kerry L.; Mayrhofer, Thomas; Z... Journal: Circulation Issue: Volume 142:Issue 24(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Association between incidental statin use and skeletal myopathies in patients treated with immune checkpoint inhibitors. Issue 1 (16th June 2021) Authors: Drobni, Zsofia D; Murphy, Sean P; Alvi, Raza M; Lee, Charlotte; Gong, Jingyi; Mosarla, Ramya C; Rambarat, Paula K; Hartmann, Sarah B; Gilman, Hannah K; Zubiri, Leyre; Raghu, Vineet K; Sullivan, Ryan J; Zafar, Amna; Zlotoff, Daniel A; Sise, Meghan E; Guidon, Amanda C; Reynolds, Kerry L; Dougan, Mi... Journal: Immunotherapy advances Issue: Volume 1:Issue 1(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Cardiovascular complications of immune checkpoint inhibitors for cancer . (30th August 2022) Authors: Thuny, Franck; Naidoo, Jarushka; Neilan, Tomas G Journal: European heart journal Issue: Volume 43:Number 42(2022) Page Start: 4458 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Cardiovascular magnetic resonance in immune checkpoint inhibitor-associated myocarditis. (29th February 2020) Authors: Zhang, Lili; Awadalla, Magid; Mahmood, Syed S; Nohria, Anju; Hassan, Malek Z O; Thuny, Franck; Zlotoff, Daniel A; Murphy, Sean P; Stone, James R; Golden, Doll Lauren Alexandra; Alvi, Raza M; Rokicki, Adam; Jones-O'Connor, Maeve; Cohen, Justine V; Heinzerling, Lucie M; Mulligan, Connor; Armanious,... Journal: European heart journal Issue: Volume 41:Number 18(2020) Page Start: 1733 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Consensus disease definitions for neurologic immune-related adverse events of immune checkpoint inhibitors. Issue 7 (19th July 2021) Authors: Guidon, Amanda C; Burton, Leeann B; Chwalisz, Bart K; Hillis, James; Schaller, Teilo H; Amato, Anthony A; Betof Warner, Allison; Brastianos, Priscilla K; Cho, Tracey A; Clardy, Stacey L; Cohen, Justine V; Dietrich, Jorg; Dougan, Michael; Doughty, Christopher T; Dubey, Divyanshu; Gelfand, Jeffrey ... Journal: Journal for immunotherapy of cancer Issue: Volume 9:Issue 7(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Consider Myocarditis When Patients Treated with Immune Checkpoint Inhibitors Present with Ocular Symptoms. (28th March 2022) Authors: Rhee, John Y; Torun, Nurhan; Neilan, Tomas G; Guidon, Amanda C Journal: Oncologist Issue: Volume 27:Number 5(2022) Page Start: e402 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. COVID-19 and immune checkpoint inhibitors: initial considerations. Issue 1 (19th May 2020) Authors: Sullivan, Ryan J; Johnson, Douglas B; Rini, Brian I; Neilan, Tomas G; Lovly, Christine M; Moslehi, Javid J; Reynolds, Kerry L Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 1(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗